The prognostic implication of skip metastasis to lateral neck in patients with papillary thyroid cancer [0.03%]
甲状腺乳头状癌患者侧颈跳跃转移的预后意义分析
Luying Gao,Xiaoyi Li,Yu Xia et al.
Luying Gao et al.
Some 16.7% of patients with skip metastases who had a median follow-up of 45 months had recurrence or persistence. Recurrence/persistence-free survival rates at 3 and 5 years were 93.3% and 74.7%, respectively.
Corporal Skip Metastases in Penile Squamous Cell Carcinoma: An Unknown and Distinct Pattern of Spread with Poor Prognosis. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.005 [0.03%]
回复Marco Bandini、Andrea Salonia和Francesco Montorsi关于Laura Elst, Manon T.A. Vreeburg, Hielke Martijn de Vries等人的信件：《阴茎鳞状细胞癌中的跳跃转移：一种未知的且具有不良预后的独特扩散模式》。欧洲泌尿肿瘤学。即将出版。https://doi.org/10.1016/j.euo.2023.09.005
Laura Elst,Manon T A Vreeburg,Oscar R Brouwer et al.
Laura Elst et al.
Corporal Skip Metastases in Penile Squamous Cell Carcinoma: An Unknown and Distinct Pattern of Spread with Poor Prognosis. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.005 [0.03%]
Laura Elst, Manon T.A. Vreeburg, Hielke Martijn de Vries等人. 阴茎鳞状细胞癌中的体腔跳跃转移：一种未知的、独特的且预后不良的扩散模式. Eur Urol Oncol. 即将出版. https://doi.org/10.1016/j.euo.2023.09.005
中文标题：阴茎鳞状细胞癌中的体腔跳跃转移：一种未知的、独特的且预后不良的扩散模式
Marco Bandini,Andrea Salonia,Francesco Montorsi
Marco Bandini
Risk factors and nomogram to predict skip metastasis in papillary thyroid carcinoma [0.03%]
乳头状甲状腺癌跳跃转移的危险因素及列线图预测模型的建立
Yingyan Zhao,Weiwei Li,Lingling Tao et al.
Yingyan Zhao et al.
Based on the clinical and ultrasonographic characteristics of patients with PTCs, the aim of our study was to investigate the risk factors and establish a nomogram for predicting the risk of skip metastases in PTCs.
Corporal Skip Metastases in Penile Squamous Cell Carcinoma: An Unknown and Distinct Pattern of Spread with Poor Prognosis [0.03%]
阴茎鳞状细胞癌的兵营样转移：一种预后不良的未知且独特的扩散模式
Laura Elst,Manon T A Vreeburg,Hielke Martijn de Vries et al.
Laura Elst et al.
Background: Penile squamous cell carcinoma (PSCC) is characterised by stepwise lymphatic dissemination. Skip metastases (SkMs) are rare metastases in the corpus cavernosum or spongiosum without continuity to the primary t...
Multicenter Study
European urology oncology. 2024 Jun;7(3):478-484. DOI:10.1016/j.euo.2023.09.005 2024
Wenhao Zhang,Guang Mu,Jingjing Huang et al.
Wenhao Zhang et al.
Moreover, the incidence of node 1 (N1) lymph node, sequential, and node 2 (N2) skip metastases were 12.2%, 12.7%, and 7.2%, respectively.
Non-Small Cell Lung Cancer With N1 Involvement or Skip Metastases Presents the Same Survival Outcome: Results From a Multicentric Study [0.03%]
N1受累或跳跃性淋巴结转移的非小细胞肺癌患者预后相同：多中心研究结果
Marco Chiappetta,Carolina Sassorossi,Filippo Lococo et al.
Marco Chiappetta et al.
Background: The prognostic difference among patients affected by NSCLC with hilar metastases only or mediastinal nodes metastases without hilar involvement (skip metastases) is still unclear. Aim of this study is to analy...
Multicenter Study
Clinical lung cancer. 2023 Nov;24(7):e275-e281. DOI:10.1016/j.cllc.2023.06.007 2023
Prevalence of Skip Metastases to Cervical Lymph-Nodes in Oral cavity Cancer in Eastern India-an observational study [0.03%]
印度东部口腔癌颈淋巴结跳跃转移的流行病学观察研究
Anupama Giresh,Pradipta Kumar Parida,Preetam Chappity et al.
Anupama Giresh et al.
To determine the prevalence of skip metastases in Oral-squamous-cell-carcinoma (OSCC). This prospective observational study was carried out on 100-cases of biopsy proven OSCC who underwent surgical treatment for the primary tumor along with neck dissection (ND).
Rate of atypical nodal metastases in surgically treated HPV-associated oropharyngeal squamous cell carcinoma [0.03%]
手术治疗的人乳头瘤病毒相关性口咽部鳞状细胞癌中非典型淋巴结转移的发生率
Lauren E Miller,Vivienne H Au,Shanmugappiriya Sivarajah et al.
Lauren E Miller et al.
The noncontiguous and skip metastases were in level IV (n = 2) and level III (n = 4), respectively.
Primary ascending colon cancer accompanying skip metastases in left shoulder skin and left neck lymph node: A case report [0.03%]
升结肠癌伴肩部及颈部跳跃性转移一例报告
Jun-Chao Zhou,Jian-Jun Wang,Tao Liu et al.
Jun-Chao Zhou et al.
Background: Lymph node skip metastases are common in lung, breast, and thyroid cancer patients, but are rare in colon cancer patients. Specifically, lymph node skip metastases occur in 1%-3% of colon cancer patients....Previous reports have demonstrated colon cancer skip metastases involving the retropancreatic and portocaval lymph nodes and Virchow's node; however, reports involving skip metastases into the left neck lymph nodes and left shoulder skin are extremely rare, as are related reports of clinical treatment
耗时 0.09256 秒，为您在
48229835
条记录里面共找到 147 篇文章 [XML]